Back to announcement
20240331_SCPI_Laporan Informasi dan Fakta Material_31621319_lamp3.pdf
Financial statement Text extracted SCPISource file signed link, expires in 15 minutes
Extracted text 1
Page 1 OCR 0.907
ORGANON Here for her health PT Organon Pharma Indonesia Tbk Sinarmas MSIG Tower 37" Floor Unit 102 & 100 Jend, Sudirrr » Kav. 21 Setiabudi, Jakarta 12920 Phone No (62) Fax No (62) 21-3110 PERNYATAAN DIREKSI TENTANG TANGGUNG JAWAB ATAS LAPORAN KEUANGAN PADA TANGGAL 31 DESEMBER 2023 DAN 2022 SERTA UNTUK TAHUN-TAHUN YANG BERAKHIR 31 DESEMBER 2023 DAN 2022 BOARD OF DIRECTORS' STATEMENT REGARDING THE RESPONSIBILITY FOR THE FINANCIAL STATEMENTS AS AT 31 DECEMBER 2023 AND 2022 AND FOR THE YEARS ENDED 31 DECEMBER 2023 AND 2022 Kami yang bertanda tangan di bawah ir 1. Nama/Name No. Identitas//D Number Alamat/Address Jabatan/ Title 2. Nama/Name No. Identitas//D Number Alamat/Address Jabatan/ Title menyatakan bahwa: "th Demiki Kami bertanggung jawab atas penyusunan dan penyajian laporan keuangan PT Organon Pharma Indonesia Tbk: Laporan keuangan PT Organon Pharma Indonesia Tbk telah disusun dan disajikan sesuai dengan Standar Akuntansi Keuangan di Indonesia, a. Semua informasi dalam laporan keuangan PT Organon Pharma Indonesia Tbk telah dimuat secara lengkap dan benar, b. Laporan keuangan PT Organon Pharma Indonesia Tbk tidak mengandung informasi atau fakta material yang tidak benar, dan tidak menghilangkan informasi atau fakta material, . Kami bertanggung jawab atas sistem pengendalian internal dalam PT Organon Pharma Indonesia Tbk. 1 pernyataan ini dibuat dengan sebenarnya. We, the undersigned: Daniel 49.536.322.8-043.000 Sinarmas MSIG Tower, 37" floor, Unit 102 & 106 Jl. Jend. Sudirman Kav. 21 DKI Jakarta Direktur Utama/President Director Yuliana 48.203.792.6-331.000 Sinarmas MSIG Tower, 37" floor, Unit 102 & 106 Jl. Jend. Sudirman Kav. 21 DKI Jakarta Direktur/Director declare that: 1 We are responsible for the preparation and presentation of the financial statements of PT Organon Pharma Indonesia Tbk: The financial statements of PT Organon Pharma Indonesia Tbk have been prepared and presented in acoordance with Indonesian Financial Accounting Standards, a. All information in the financial statements of PT Organon Pharma Indonesia Tbk have been disclosed in a comploto and truthful manner: b. The financial statements of PT Organon Pharma Indonesia Tbk do not contain any incorrect information or material fact, nor do they omit information or material fact: We are responsible for PT Organon Pharma Indonesia Tbk internal control system. Thus this statement Is made trutnfully. Atas nama dan mewakili Dewan Direksi/For and on behalf of the Board of Directors Jakarta, 30 Maret/March 2024 Daniel Direktur Utama/President Direct Sa Tx O9AKX59963! Yuliana Direktur/Director
Names mentioned 1 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.